Results 71 to 80 of about 15,338 (177)
Acta Clinica CroaticaThe aim of this study was to determine the frequency of hypophosphatemia in female patients with iron deficiency anemia (IDA) treated parenterally with ferric carboxymaltose (FCM).
Nikolina Brkić +3 more
doaj +1 more source
Symptomatic severe hypophosphatemia after intravenous ferric carboxymaltose
JGH Open, 2019 Intravenous iron is commonly prescribed for treatment of iron deficiency, with modern formulations demonstrating an acceptable safety profile in the majority of patients.
Wendy Fang +3 more
doaj +1 more source
Hypophosphatemia Due to Adefovir Treatment [PDF]
Mediterranean Journal of Infection, Microbes and Antimicrobials, 2012 Adefovir dipivoxil is an orally effective prodrug excreted unchanged in urine by glomerular filtration and tubular secretion. While it effectively suppresses hepatitis B virus replication, it may cause nephrotoxicity characterized by severe ...
Nazlım AKTUĞ DEMİR +4 more
doaj
Pakistan Journal of Medicine and DentistryBackground: Diabetic ketoacidosis (DKA) is a life-threatening complication of diabetes mellitus characterized by hyperglycemia, ketosis, and acidosis. Hypophosphatemia is a frequently overlooked yet clinically significant electrolyte disturbance during ...
Sadaf Abdullah +5 more
doaj +1 more source
Danger of co-administration ferric carboxymaltose and denosumab: hypophosphatemia
The Egyptian Journal of Internal MedicineBoth denosumab-induced hypocalcemia and ferric carboxymaltose infusion-related hypophosphatemia have been extensively documented. There are significant risks associated with combining ferric carboxymaltose parenteral infusions and denosumab, including ...
Aysun Seker, Nurdan Senturk Durmus
doaj +1 more source
Recurrent Severe Hypophosphatemia Following Intravenous Ferric Carboxymaltose Infusion: A Case Report. [PDF]
CureusEnchill LA +4 more
europepmc +1 more source